https://www.selleckchem.com/pr....oducts/NVP-AUY922.ht
Results The clinical efficacy of the observation group was better than that of the control group (P0.05). The level of plasma 3-MST in the observation group was higher than that in the control group, and the level of plasma Aβ42 was lower than that in the control group (P less then 0.05). No serious adverse reactions occurred during the treatment period in both groups. Conclusion Butylphthalide sequential therapy combined with dual antiplatelet therapy is effective in the treatment of elderly ACI. It can effectively improve the plasm
Like
Comment
Share
